Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
10/2003
10/02/2003WO2003080608A2 Quinoline and aza-indole derivatives and their use as 5-ht6 ligands
10/02/2003WO2003080580A2 Quinoline derivatives and their use as 5-ht6 ligands
10/02/2003WO2003080579A1 Novel adamantane derivatives
10/02/2003WO2003080578A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
10/02/2003WO2003080577A2 Amidoacetonitrile compounds
10/02/2003US20030187147 Reacting a iminoester with polymer
10/02/2003US20030187033 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents
10/02/2003US20030186995 Substituted bicyclic derivatives useful as anticancer agents
10/02/2003US20030186985 Oxyiminoalkanoic acid derivatives
10/02/2003CA2479150A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
10/01/2003EP1347950A1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
10/01/2003CN1446211A Indole derivatives useful for treatment of CNS disorders
09/2003
09/30/2003US6627767 Controlling cellular metabolism
09/30/2003US6627642 Solved by the present invention is to provide a quinolinone derivative formulation, and its production method, having for its active ingredient the beta crystal form and/or gamma crystal form of the quinolinone derivative represented with
09/25/2003WO2003078398A1 NON-PEPTIDE GnRH ANTAGONISTS
09/25/2003WO2003078397A1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
09/25/2003WO2003077847A2 Substituted amides
09/25/2003WO2003029199A9 Benzene derivatives, process for preparing the same and use thereof
09/25/2003WO2003013530A3 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives as nmda antagonists
09/25/2003US20030181724 Process for the preparation of quinoline derivatives
09/25/2003US20030181446 Novel N-acylated heterocycles
09/25/2003US20030181390 Sustained release of aminobutyric acid using prodrugs such as L-1-naphthylalanine-gabapentin, administered for prophylaxis of nervous system disorders, as anxiolytics, antidepressants or antiinflammatory agents; drug delivery
09/25/2003CA2479069A1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
09/25/2003CA2478713A1 Non-peptide gnrh antagonists
09/24/2003EP1345907A2 7-heterocyclyl quinoline and thieno 2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
09/24/2003EP1345892A2 Acylaminoalkyl-substituted benzenesulfonamide derivatives
09/24/2003EP1345603A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/24/2003EP1178965B1 Quinoline derivatives as inhibitors of mek enzymes
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003EP0973746B1 Substituted 3-cyano quinolines
09/24/2003CN1444641A Lubricating compositions containing aromatized 1,2-dihydro-2,2,4-trimethylquinoline polymers
09/24/2003CN1444563A Quinoline and quinazoline derivatives
09/24/2003CN1444562A Rice blast control agents
09/24/2003CN1122039C Process for reducing prochiral ketone to produce optically active alcohol of high optical purity
09/24/2003CN1122024C Process for converting hydroxy heteroaromatics to arylamines
09/23/2003US6624309 Administering 4-heterocyclicbenzamide derivative
09/23/2003US6624304 Halogenation, hydrofluorination, cyclization, salt formation, cyclization; reaction with piperazine; separation
09/23/2003US6624152 Inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention relates to pharmaceutical formulations comprising these compounds and methods of using them for inflammatory and autoimmune diseases
09/23/2003CA2127110C Carbamates and crop protection agents containing them
09/18/2003WO2003076422A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076407A1 Novel chalcone derivatives and uses thereof
09/18/2003WO2003076374A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
09/18/2003WO2003075836A2 Cathepsin cysteine protease inhibitors
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/18/2003WO2003040256A3 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
09/18/2003WO2003039454A8 Beta-secretase inhibitors and methods of use
09/18/2003WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
09/18/2003WO2002062750A9 Cannabinoid receptor ligands
09/18/2003WO2002034745A8 Chemokine receptor binding heterocyclic compounds
09/18/2003US20030176703 Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and N-(4-methoxyphenyl)-3-chloropropionamide
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030176485 Calcium receptor active compounds
09/18/2003US20030176459 For controlling infection of fungi of the genus Pyricularia which are a kind of mold fungi and belong to deuteromycotina
09/18/2003US20030176448 Mitochondria protecting agents for treating mitochondria associated diseases
09/18/2003CA2478921A1 Novel chalcone derivatives and uses thereof
09/17/2003EP1343796A2 Compounds and methods
09/17/2003EP1343766A1 Cyclization process step in the making of quinolones and naphthyridines
09/17/2003EP1343765A1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents
09/17/2003EP1343753A2 Antimicrobial agents
09/17/2003EP1196411B1 Bradykinin b1 receptor antagonists
09/17/2003EP1095021B1 Quinoline derivatives
09/17/2003EP0977737B1 Crf antagonistic quino- and quinazolines
09/17/2003CN1443179A Aniline derivatives
09/17/2003CN1443171A Novel heteroaryl derivatives and use thereof as pharmaceuticals
09/17/2003CN1443169A Chemical process for extraction of 2-hydroxy pyridine derivatives, 2-hydroxyquinoline, and 2-hydroxybenzothiazole
09/17/2003CN1443155A Compounds to treat alzheimer's disease
09/17/2003CN1121391C Substituted 3-cyano quinolines
09/17/2003CN1121379C Synthesis and use of retinene derivative having negative hormone and/or antagonist activities
09/17/2003CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors
09/16/2003US6620827 PPARγ modulators
09/12/2003WO2003074488A1 Method for producing ethyl ether of 6-fluorine-7-chlorine-1.4-dihydro-4-oxo-3-quinolinecarboxilic acid
09/12/2003WO2003074025A2 Pressurised metered dose inhalers containing solutions of beta-2 agonists
09/12/2003WO2002059239A3 Lubricating oil composition with improved soot dispersing properties comprising an aromatic oligomer
09/12/2003WO2002058695A9 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/12/2003WO2002004443A3 Heterocycle carboxamides as antiviral agents
09/11/2003WO2003074024A1 Formoterol superfine formulation
09/11/2003US20030171399 Quinolinyl and benzothiazolyl modulators
09/11/2003US20030171352 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
09/11/2003US20030170381 Piezoelectric element and process for production thereof
09/11/2003US20030168970 Luminescent element material and luminescent element comprising the same
09/10/2003EP1341785A2 HYDROLYSIS OF R(R*,R*)]-2-(4-FLUOROPHENYL)-$g(b),$g(d) -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4- (PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE
09/10/2003EP1341774A1 Fused heteroaromatic glucokinase activators
09/10/2003EP1341773A2 Substituted 1,3,5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
09/10/2003EP1341542A2 Organic compounds
09/10/2003EP1131321B1 Indole derivatives and their use as serotonin receptor ligands
09/10/2003EP0912570B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
09/10/2003CN1120878C Method for coal liquefaction
09/09/2003US6617422 Peptide nucleic acid monomers and oligomers
09/09/2003US6617336 Treatment of urinary incontinence, venous insufficiency, migraine or gastrointestinal disorders
09/09/2003US6617317 Boronic ester and acid compositions
09/09/2003CA2290712C Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
09/04/2003WO2003062209A3 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
09/04/2003WO2003045313A3 2-aminoquinoline compounds
09/04/2003US20030166936 Chemical intermediates for microbiocides
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166679 Fluorinated heterocyclic compounds and methods of synthesis
09/04/2003US20030166678 Carboxylated heterocyclic compounds and methods of synthesis
09/04/2003US20030166677 Chlorinated heterocyclic compounds and methods of synthesis
09/04/2003US20030166676 Dichloroflosequinan; phosphodiesterase inhibitor
09/04/2003US20030166663 E.g.,4-tert-butyl-N-(4-piperazin-1-yl-quinolin-6-yl)benzene-su lfonamide or 5-chloro-3-methyl-benzo(b)thiophene-2-sulfonic acid (4-piperazin-1-yl-quinolin-6-yl) amide; obesity; food intake reduction; bind to 5-HT6 receptors; antiseraton agents
1 ... 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 ... 277